(Date:11/5/2009)...GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ -...s financial results for the third quarter ended Se....6 million ($0.04 per share) for the three months ... $6.8 million ($0.08 per share) in the comparable ...er 30, 2009, GenVec,s net loss was $14.1 million (...
(Date:11/5/2009)...PARSIPPANY, N.J., Nov. 5 DSM Pharm...e a manufacturing alliance with Galenix, Saint Jea... commercial scale manufacturing partner for Galeni... and Galenix will collaborate on business developm...ry technologies, based on the strength of Galenix ...
(Date:11/5/2009)...RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCa...ding supplier of innovative products for processin...ults for the first quarter of fiscal 2010. ,, F...ny reported revenues of $5.2 million, a 15 percent...st quarter a year ago. The Company said the key co...
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7...lif., May 8 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... Bank of America Health Care Conference on Thursda...parties may access a live webcast of the,presentat...wt/page/event_calendar , It is recommended that l...ter and download any necessary software. For those...
... Calif., May 8 Beckman Coulter,Inc. (NYSE: BEC )...of,products that simplify, automate, and innovate ...ul Glyer, Beckman Coulter,s Senior Vice President,... the following,conferences:, (Logo: http://ww... Bank of America 2008 Healthcare Conference on Wed...
...., May 8 BioSpace, the world,s leading,online bio...pany, unveiled,this morning the 2008 Bio NC(TM) Ho... Carolina., (Photo: http://www.newscom.com/cgi-b...ewscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), T...pharmaceutical and,medical device communities in R...
Other Biology Technology:Beckman Coulter to Present at Upcoming Healthcare Conferences 2BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2Rabbit Anti-ATF4, phospho (Ser245) Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-nicotinic Acetylcholine Receptor Monoclonal Antibody, Unconjugated, Clone 88B from Abcam
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Biology Products: